ANDA 78783, held by Strides Pharma Intl. Tramadol Hydrochloride.
As of Nov 16, 2026, ANDA 78783 (Tramadol Hydrochloride), held by Strides Pharma Intl, was first approved by FDA on Nov 13, 2009, with 14 approved supplements and 0 published complete response letters.
| Sep 20, 2011 | Supplement 1Efficacy (new indication or use) | Approved | None posted |
| Nov 13, 2009 | Original application | Approved |
| Tramadol Hydrochloride100MG · tablet, extended release;oral | Tramadol Hydrochloride | Discontinued |
| Tramadol Hydrochloride200MG · tablet, extended release;oral | Tramadol Hydrochloride | Discontinued |
| Tramadol Hydrochloride300MG · tablet, extended release;oral | Tramadol Hydrochloride | Discontinued |
| Jun 18, 2026 | Supplement 18REMS | Approved | None posted |
| Dec 22, 2025 | Supplement 17Labeling · Standard review | Approved | None posted |
| Oct 21, 2025 | Supplement 15Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 16REMS | Approved | None posted |
| Dec 15, 2023 | Supplement 14Labeling · Standard review | Approved | None posted |
| Sep 10, 2021 | Supplement 13Labeling · Standard review | Approved | None posted |
| Mar 4, 2021 | Supplement 12Labeling · Standard review | Approved | None posted |
| Oct 9, 2019 | Supplement 10Labeling · Standard review | Approved | None posted |
| Sep 21, 2018 | Supplement 9Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 8REMS | Approved | None posted |
| Aug 29, 2017 | Supplement 7Labeling · Standard review | Approved | None posted |
| Aug 21, 2017 | Supplement 6Labeling · Standard review | Approved | None posted |
| Aug 21, 2017 | Supplement 4Labeling · Standard review | Approved | None posted |
| Sep 20, 2011 | Supplement 1Efficacy (new indication or use) | Approved | None posted |
| Nov 13, 2009 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters